COUPLED SORTING AND ELECTRIC TREATMENT OF BIOLOGICAL CELLS
20220049208 · 2022-02-17
Inventors
Cpc classification
C12M35/02
CHEMISTRY; METALLURGY
C12M47/06
CHEMISTRY; METALLURGY
International classification
C12M1/42
CHEMISTRY; METALLURGY
C12N13/00
CHEMISTRY; METALLURGY
Abstract
The present application provides a method for lysis or electroporation of cells in a biological sample including the following steps: passing cells of the sample, suspended in a fluid, through a flow path with a preset flow speed, wherein the flow path runs through a detection apparatus for detecting individual cells and wherein the flow path includes at least two electrodes for generating an electric field, which electrodes are located downstream of the detection apparatus and which electrodes are coated with a dielectric material with a relative permittivity greater than 3.9, wherein the coaling at least covers the surface of the electrodes that faces the flow path, and when the presence of a specific cell is detected in the detection apparatus, then an electric field is generated between the electrodes when the detected cell passes between the electrodes in dependence of the flow speed, wherein the electric field causes electroporation or lysis of the cell.
Claims
1. A method for lysis or electroporation of cells in a biological sample comprising the following steps: passing cells of the sample, preferably suspended in a fluid, through a flow path with a flow speed, wherein the flow path runs through a detection apparatus for detecting individual cells and wherein the flow path comprises at least two electrodes for generating an electric field, which electrodes are located downstream of the detection apparatus and which electrodes are coated with a dielectric material with a relative permittivity greater than 3.9, wherein the coating at least covers the surface of the electrodes that faces the flow path; and when the presence of a specific cell is detected in the detection apparatus, then an electric field is generated between the electrodes when the detected cell passes between the electrodes in dependence of the flow speed, wherein the electric field causes electroporation or lysis of the cell.
2. The method according to claim 1, wherein the strength of the electric field is in the range of 500 V/cm to 50 kV/cm.
3. The method according to claim 1, wherein the potential difference between the electrodes for generating the electric field is in the range of 1 V to 100V.
4. The method according to claim 1, wherein the biological sample comprises cells of a first group and cells of a second group, wherein cells of the first group are exposed to a first electric field with a first electric field strength and cells of the second group are exposed to a second electric field with a second electric field strength.
5. The method according to claim 4, wherein the first electric field causes lysis of the cells of the first group and the second electric field causes reversible electroporation of the cells of the second group.
6. The method according to claim 1, wherein the biological sample comprises cells of a first group and a second group, wherein cells of the first group are exposed to a first electric field with a first electric field strength that causes lysis or reversible electroporation of the cells of the first group and wherein the electric field is deactivated for cells of the second group.
7. The method according to claim 1, wherein the dielectric material has a thickness below 1 μm.
8. The method according to claim 1, wherein the distance between the electrodes is below 1 mm.
9. The method according to claim 1, wherein the electric field is a periodic field with a frequency in the range of 0.1 Hz to 10 MHz, wherein the wave form of the electric field is a square wave, a sinusoidal wave or at least one pulse per period
10. The method according to claim 1, wherein specific cells are collected after flowing through the chamber.
11. The method according to claim 1, wherein prior to passing the cells through the detection apparatus, electroporation for loading the cells with a marker is conducted.
12. An apparatus for specific lysis of cells in a biological sample with a flow path, that runs through a detection apparatus for detecting individual cells and with a pump unit that passes the cells through the flow path with a flow speed, wherein the flow path comprises at least two electrodes for generating an electric field, which electrodes are located downstream to the detection apparatus and which electrodes are coated with a dielectric material with a relative permittivity greater than 3.9, wherein the coating at least covers the surface of the electrodes that faces the flow path.
13. The apparatus of claim 12, wherein the apparatus further comprises a unit that activates the electric field between the electrodes when a detected cell passes between the electrodes in dependence of the flow speed.
14. The apparatus according to claim 12, wherein the distance between the electrodes is below 1 mm.
15. The apparatus according to claim 12, comprising at least two further electrodes upstream of the detection apparatus.
Description
FIGURES
[0045]
[0046]
[0047]
EXAMPLES
Production of Titanium-Oxide Coated Electrodes
[0048] Grade 2 titanium foil (commercially pure titanium, cpTi, 99.2% pure) was cut in dimensions of 60×10 mm. These electrodes were cleaned and coated using a previously established protocol (Wassermann et al. 2016). This treatment yields an average oxide layer thickness of 500-600 nm. Electroporation reservoirs were assembled using double-sided 81.3 μm thick adhesive tape (Adhesive Research, Arcare 90445) spaced 2.5 mm apart forming a 12,15 μl channel.
Cell Culture
[0049] Human embryonic kidney cells 293T (supplied by the Department of Nanobiotechnology of the University of Natural Resources and Life Sciences, Vienna) were cultivated at 37° C. and 5% CO.sub.2 in DMEM (Thermo Fisher, 41965) supplemented with 10% FBS (Thermo Fisher, 10500) and 1% Pen/Strep Antibiotic—Antimycotic (Thermo Fisher, 15240). Cells were passaged by washing with PBS (1× from stock: Thermo Fisher, 70011044) followed by trypsinization (0.25%, Thermo Fisher, 25200) for 5 min at 37° C. Any sterile protocols were processed in biological safety cabinets. (Herasafe KS, Class II, Thermo Fisher, 51022488)
Sample Preparation
[0050] Cells were washed with PBS, detached by trypsinization and re-suspended in supplemented DMEM Medium. Electroporation buffer (EPB) was prepared from autoclaved 250 mM sucrose solution. PBS was added to adjust the desired sample conductivities. Conductivity was measured using a conductivity meter (B-771 LAQUAtwin, HORIBA Advanced Techno). Cells were centrifuged for 5 min at 400 g (RT), supernatant discarded and re-suspended with EPB. After two washing steps, cells were counted and adjusted to 1×10^6/ml with the next reconstitution. Final conductivity was recorded. If the suspension deviated more than 10 μS/cm from the calibrated EPB, the washing step is repeated until conductivity is within this range. Cell death from sample preparation was also assessed. Only samples containing more than 90% live cells, as determined by Hoechst 33342 stain were used for experiments.
Transfection
[0051] Cells were kept in a sterile working environment. 9 μl were placed on hydrophobic parafilm and mixed with 1 μl vector stock solution for a final working concentration of 25 ng/ml pTurboRFP-N (Evrogen, FP232) and 0.5 mM MgCl2. The suspension was aspirated into the electroporation chamber (
Electroporation and Imaging
[0052] 293T cell lysis is used as an indirect readout to analyze the biological impact of capacitively coupled electric fields across a range of parameters. Cells in EP buffer were transferred to hydrophobic parafilm in 10 μl droplets and aspirated with the electroporation tip prototype. Electric fields were induced by applying the according voltage waveforms by a function generator (DG4102, Rigol) connected to a voltage amplifier (Falco WMA-300, Falco Systems, Netherlands). Voltages and current (via a 2 Ω resistor) were monitored by an oscilloscope (DS1104B, Rigol). Cells were ejected onto parafilm and mixed with a 10 μg/ml (10×) stock solution of in PBS for a final concentration of 1 μg/ml. The sample was transferred to a hemocytometer (Thoma, Optik Labor) and imaged by a digital camera (Prosilica GT, Allied Vision) mounted on an inverted microscope (CKX41 Fluo V2, Olympus). Bright-field images were recorded for total cell count. To identify lysed cells, Hoechst 33342 viability dye was excited at 360 nm using a UV light source (X-Cite 120Q, Excelitas Technologies) and emission above 420 nm imaged for further analysis. For permeabilization experiments, the cell suspension is mixed 1:10 with a 30 μg/μl solution of Propidium Iodide (PI) prior to field exposure. The dye is prepared from dilution of a 1 mg/ml stock with electroporation buffer to limit any conductivity change. To identify permeabilized cells, the membrane impermeable PI was excited from 480-550 nm using a UV light source (X-Cite 120Q, Excelitas Technologies) and emission above 590 nm imaged for further analysis.
Data Analysis
[0053] Lysis images were analysed in Fiji (Schindelin et al. 2012) by adjusting the threshold to include positive cells only, isolating high-contrast live cells in bright-field and stained dead cells in fluorescence images. After converting images to binary, cell count was performed by particle analysis function. Results are displayed as percentage lysed, excluding the fraction of dead cells from sample preparation, which means that the control is always displayed as zero percent lysis. PI-positive cells were counted manually from a bright-field and red fluorescence overlay. Controls were overexposed to the point where PI-negative cells remain invisible. This setting is then applied to samples subjected to electric fields. Dead cells show high-PI fluorescence, look visibly dead in bright-field and are calculated equally as in lysis experiments. Permeabilized cells are displayed as the fraction of visibly live cells with any PI fluorescence.
Device Assembly and Use
[0054] As shown in
[0055] Targeted permeabilization of single cells or particles within a fluid flowing through a microfluidic device (3) occurs after passing through the flow cytometer analysis region. The apparatus includes an electric control system (4) connected to the flow cytometer control system (5) that outputs an electrical signal to the microfluidic device (3) bearing electrodes covered with a high-k passivation layer that couple an electric field into the fluid flowing through the microfluidic device. The electric fields permeabilize the cells or particles after they passed through the FC analysis to allow either the targeted irreversible electroporation of single cells via negative or positive selection based on the FC analysis or to allow the targeted reversible electroporation of cells via negative or positive selection based on the FC analysis.
Lysis and Electroporation Settings
[0056] The experiments described are intended to demonstrate controllable low voltage cell lysis in the electrode chamber microfluidic device.
[0057]
[0058]
[0059]
[0060]
[0061] For uptake demonstration,
[0062]
[0063]
[0064]
[0065]